Comparison between DECCAN CHRONICLE HOLDINGS IPO and INDOCO REMEDIES IPO.
DECCAN CHRONICLE HOLDINGS IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while INDOCO REMEDIES IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| DECCAN CHRONICLE HOLDINGS IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of DECCAN CHRONICLE HOLDINGS IPO is up to ₹149.28 Cr whereas the issue size of the INDOCO REMEDIES IPO is up to ₹73.50 Cr. The final issue price of DECCAN CHRONICLE HOLDINGS IPO is ₹162.00 per share and of INDOCO REMEDIES IPO is ₹245.00 per share.
| DECCAN CHRONICLE HOLDINGS IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹162.00 per share | ₹220.00 per share |
| Issue Price (Upper) | ₹194.00 per share | ₹245.00 per share |
| Issue Price (Final) | ₹162.00 per share | ₹245.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 92,15,060 shares | 30,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹149.28 Cr | up to ₹73.50 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 92,15,060 shares | 30,00,000 shares |
| Issue Size Total (Amount) | up to ₹149.28 Cr | up to ₹73.50 Cr |
DECCAN CHRONICLE HOLDINGS IPO opens on Nov 25, 2004, while INDOCO REMEDIES IPO opens on Dec 17, 2004. The closing date of DECCAN CHRONICLE HOLDINGS IPO and INDOCO REMEDIES IPO is Dec 07, 2004, and Dec 23, 2004, respectively.
DECCAN CHRONICLE HOLDINGS IPO P/E ratio is , as compared to INDOCO REMEDIES IPO P/E ratio of .
In the DECCAN CHRONICLE HOLDINGS IPO Retail Individual Investors (RII) are offered 23,03,765 shares while in INDOCO REMEDIES IPO retail investors are offered 23,03,765 shares. Qualified Institutional Buyers (QIB) are offered 55,29,036 shares in DECCAN CHRONICLE HOLDINGS IPO and 15,00,000 shares in INDOCO REMEDIES IPO.
| DECCAN CHRONICLE HOLDINGS IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 55,29,036 shares | 15,00,000 shares |
| NII | 13,82,259 shares | 7,50,000 shares |
| RII | 23,03,765 shares | 7,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 92,15,060 shares | 30,00,000 shares |
DECCAN CHRONICLE HOLDINGS IPO subscribed in total, whereas INDOCO REMEDIES IPO subscribed .
